{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:24:32Z","timestamp":1779927872855,"version":"3.53.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071759"],"award-info":[{"award-number":["82071759"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Hope Run Special Fund of Cancer Foundation of China","award":["LC2020A14"],"award-info":[{"award-number":["LC2020A14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to evaluate the efficiency of hippocampal avoidance whole-brain radiotherapy with a simultaneous integrated boost (HA-WBRT-SIB) treating brain metastases (BM) and utility of the Hopkins Verbal Learning Test-Revised (HVLT-R) (Chinese version) in Chinese lung cancer patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Lung cancer patients with BM undergone HA-WBRT-SIB at our center were enrolled. Brain magnetic resonance imaging, The HVLT total learning score, and side effects were evaluated before radiotherapy and 1, 3, 6, and 12 months after radiotherapy. This study analyzed the overall survival rate, progression-free survival rate, and changes in HVLT-R immediate recall scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty patients were enrolled between Jan 2016 and Jan 2020. The median follow-up time was 14.2 months. The median survival, progression-free survival, and intracranial progression-free survival of all patients were 14.8 months, 6.7 months and 14.8 months, respectively. Multivariate analysis indicated that male sex and newly diagnosed stage IV disease were associated with poor overall survival and progression-free survival, respectively. HVLT-R scores at baseline and 1, 3, and 6 months after radiotherapy were 21.94\u2009\u00b1\u20092.99, 20.88\u2009\u00b1\u20093.12, 20.03\u2009\u00b1\u20093.14, and 19.78\u2009\u00b1\u20092.98, respectively. The HVLT-R scores at 6 months after radiotherapy decreased by approximately 9.8% compared with those at baseline. No grade 3 toxicities occurred in the entire cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HA-WBRT-SIB is of efficiency and cognitive-conserving in treating Chinese lung cancer BM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>This study was retrospectively registered on ClinicalTrials.gov in 24th Feb, 2024. The ClinicalTrials.gov ID is NCT06289023.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12559-1","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:03:34Z","timestamp":1722027814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhuoran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jima","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"12559_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 Countries[J]. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"12559_CR2","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","volume":"19","author":"DN Cagney","year":"2017","unstructured":"Cagney DN, Martin AM, Catalano PJ, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study[J]. Neuro Oncol. 2017;19:1511\u201321. https:\/\/doi.org\/10.1093\/neuonc\/nox077.","journal-title":"Neuro Oncol"},{"key":"12559_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ijrobp.2007.02.016","volume":"68","author":"A Ghia","year":"2007","unstructured":"Ghia A, Tome WA, Thomas S, et al. Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation[J]. Int J Radiat Oncol Biol Phys. 2007;68:971\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.02.016.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12559_CR4","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez de Dios N, Cou\u00f1ago F, Murcia-Mej\u00eda M, et al. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study[J]. J Clin Oncol 2021;39:3118\u20133127. DOI: 10.1200\/jco.21.00639.https:\/\/doi.org\/10.1200\/jco.21.00639.","DOI":"10.1200\/jco.21.00639"},{"key":"12559_CR5","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","volume":"32","author":"V Gondi","year":"2014","unstructured":"Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial[J]. J Clin Oncol. 2014;32:3810\u20136. https:\/\/doi.org\/10.1200\/JCO.2014.57.2909.","journal-title":"J Clin Oncol"},{"key":"12559_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1200\/JCO.19.02767","volume":"38","author":"PD Brown","year":"2020","unstructured":"Brown PD, Gondi V, Pugh S, et al. Hippocampal avoidance during whole-brain Radiotherapy Plus Memantine for patients with brain metastases: Phase III Trial NRG oncology CC001[J]. J Clin Oncol. 2020;38:1019\u201329. https:\/\/doi.org\/10.1200\/JCO.19.02767.","journal-title":"J Clin Oncol"},{"key":"12559_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jtho.2020.12.024","volume":"16","author":"JSA Belderbos","year":"2021","unstructured":"Belderbos JSA, De Ruysscher DKM, De Jaeger K, et al. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation with or without Hippocampus Avoidance in SCLC (NCT01780675)[J]. J Thorac Oncol. 2021;16:840\u20139. https:\/\/doi.org\/10.1016\/j.jtho.2020.12.024.","journal-title":"J Thorac Oncol"},{"key":"12559_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijrobp.2016.09.020","volume":"97","author":"M Ferro","year":"2017","unstructured":"Ferro M, Chiesa S, Macchia G, et al. Intensity modulated Radiation Therapy with Simultaneous Integrated Boost in patients with brain oligometastases: a phase 1 study (ISIDE-BM-1)[J]. Int J Radiat Oncol Biol Phys. 2017;97:82\u201390. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.09.020.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12559_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/s1470-2045(22)00271-6","volume":"23","author":"K Gaebe","year":"2022","unstructured":"Gaebe K, Li AY, Park A, et al. Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis[J]. Lancet Oncol. 2022;23:931\u20139. https:\/\/doi.org\/10.1016\/s1470-2045(22)00271-6.","journal-title":"Lancet Oncol"},{"key":"12559_CR10","doi-asserted-by":"publisher","unstructured":"Ni M, Jiang A, Liu W, et al. Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study[J]. Radiat Oncol. 2020;15. https:\/\/doi.org\/10.1186\/s13014-020-01509-3.","DOI":"10.1186\/s13014-020-01509-3"},{"key":"12559_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/0284186x.2018.1562207","volume":"58","author":"W Jiang","year":"2019","unstructured":"Jiang W, Haque W, Verma V, Butler B, Teh BS. Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes[J]. Acta Oncol. 2019;58:491\u20138. https:\/\/doi.org\/10.1080\/0284186x.2018.1562207.","journal-title":"Acta Oncol"},{"key":"12559_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.lungcan.2016.04.003","volume":"96","author":"L Zhou","year":"2016","unstructured":"Zhou L, He J, Xiong W, et al. Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: results of phase I dose-escalation study[J]. Lung Cancer. 2016;96:93\u2013100. https:\/\/doi.org\/10.1016\/j.lungcan.2016.04.003.","journal-title":"Lung Cancer"},{"key":"12559_CR13","doi-asserted-by":"publisher","unstructured":"Shi J, Tian J, Wei M, Miao Y, Wang Y. The utility of the Hopkins Verbal Learning Test (Chinese version) for screening dementia and mild cognitive impairment in a Chinese population[J]. BMC Neurol. 2012;12. https:\/\/doi.org\/10.1186\/1471-2377-12-136.","DOI":"10.1186\/1471-2377-12-136"},{"key":"12559_CR14","doi-asserted-by":"publisher","DOI":"10.1076\/clin.12.1.43.1726","author":"RHB Benedict","year":"2010","unstructured":"Benedict RHB, Schretlen D, Groninger L, Brandt J. Clin Neuropsychol. 2010;12:43\u201355. https:\/\/doi.org\/10.1076\/clin.12.1.43.1726. Hopkins Verbal Learning Test \u2013 Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability[J]."},{"key":"12559_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/s2213-2600(17)30262-x","volume":"5","author":"J-J Yang","year":"2017","unstructured":"Yang J-J, Zhou C, Huang Y, et al. Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial[J]. Lancet Respiratory Med. 2017;5:707\u201316. https:\/\/doi.org\/10.1016\/s2213-2600(17)30262-x.","journal-title":"Lancet Respiratory Med"},{"key":"12559_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fonc.2018.00415","volume":"8","author":"TP Robin","year":"2018","unstructured":"Robin TP, Rusthoven CG. Strategies to preserve cognition in patients with brain metastases: a Review[J]. Front Oncol. 2018;8:415. https:\/\/doi.org\/10.3389\/fonc.2018.00415.","journal-title":"Front Oncol"},{"key":"12559_CR17","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/annonc\/mdr003","volume":"22","author":"F Barlesi","year":"2011","unstructured":"Barlesi F, Gervais R, Lena H, et al. Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07\u2009\u2013\u200901)[J]. Ann Oncol. 2011;22:2466\u201370. https:\/\/doi.org\/10.1093\/annonc\/mdr003.","journal-title":"Ann Oncol"},{"key":"12559_CR18","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1200\/jco.2003.12.122","volume":"21","author":"MP Mehta","year":"2003","unstructured":"Mehta MP, Rodrigus P, Terhaard CHJ, et al. Survival and neurologic outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases[J]. J Clin Oncol. 2003;21:2529\u201336. https:\/\/doi.org\/10.1200\/jco.2003.12.122.","journal-title":"J Clin Oncol"},{"key":"12559_CR19","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial[J]. JAMA. 2006;295:2483\u201391. https:\/\/doi.org\/10.1001\/jama.295.21.2483.","journal-title":"JAMA"},{"key":"12559_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV, et al. Effect of Radiosurgery alone vs Radiosurgery with Whole Brain Radiation Therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical Trial[J]. JAMA. 2016;316:401\u20139. https:\/\/doi.org\/10.1001\/jama.2016.9839.","journal-title":"JAMA"},{"key":"12559_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/s1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial[J]. Lancet Oncol. 2009;10:1037\u201344. https:\/\/doi.org\/10.1016\/s1470-2045(09)70263-3.","journal-title":"Lancet Oncol"},{"key":"12559_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1227\/01.NEU.0000249272.64439.B1","volume":"60","author":"EL Chang","year":"2007","unstructured":"Chang EL, Wefel JS, Maor MH, et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone[J]. Neurosurgery. 2007;60:277\u201383. https:\/\/doi.org\/10.1227\/01.NEU.0000249272.64439.B1.","journal-title":"Neurosurgery"},{"key":"12559_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/s1470-2045(17)30441-2","volume":"18","author":"PD Brown","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial[J]. Lancet Oncol. 2017;18:1049\u201360. https:\/\/doi.org\/10.1016\/s1470-2045(17)30441-2.","journal-title":"Lancet Oncol"},{"key":"12559_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/jco.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study[J]. J Clin Oncol. 2011;29:134\u201341. https:\/\/doi.org\/10.1200\/jco.2010.30.1655.","journal-title":"J Clin Oncol"},{"key":"12559_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/jamaoncol.2015.1145","volume":"1","author":"H Aoyama","year":"2015","unstructured":"Aoyama H, Tago M, Shirato H, Japanese Radiation Oncology Study Group I. Stereotactic Radiosurgery with or without whole-brain Radiotherapy for Brain metastases: secondary analysis of the JROSG 99\u2009\u2013\u20091 randomized clinical Trial[J]. JAMA Oncol. 2015;1:457\u201364. https:\/\/doi.org\/10.1001\/jamaoncol.2015.1145.","journal-title":"JAMA Oncol"},{"key":"12559_CR26","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ijrobp.2009.03.032","volume":"76","author":"F Hsu","year":"2010","unstructured":"Hsu F, Carolan H, Nichol A, et al. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1\u20133 brain metastases: a feasibility study using volumetric modulated arc therapy[J]. Int J Radiat Oncol Biol Phys. 2010;76:1480\u20135. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.03.032.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12559_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijrobp.2007.05.038","volume":"69","author":"AN Gutierrez","year":"2007","unstructured":"Gutierrez AN, Westerly DC, Tome WA, et al. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study[J]. Int J Radiat Oncol Biol Phys. 2007;69:589\u201397. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.05.038.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12559_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-020-03491-y","volume":"148","author":"ES Lebow","year":"2020","unstructured":"Lebow ES, Hwang WL, Zieminski S, et al. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases[J]. J Neurooncol. 2020;148:81\u20138. https:\/\/doi.org\/10.1007\/s11060-020-03491-y.","journal-title":"J Neurooncol"},{"key":"12559_CR29","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1002\/cncr.32787","volume":"126","author":"I Popp","year":"2020","unstructured":"Popp I, Rau S, Hintz M, et al. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases[J]. Cancer. 2020;126:2694\u2013703. https:\/\/doi.org\/10.1002\/cncr.32787.","journal-title":"Cancer"},{"key":"12559_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12885-020-07011-z","volume":"20","author":"AL Grosu","year":"2020","unstructured":"Grosu AL, Frings L, Bentsalo I, et al. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG)[J]. BMC Cancer. 2020;20:532. https:\/\/doi.org\/10.1186\/s12885-020-07011-z.","journal-title":"BMC Cancer"},{"key":"12559_CR31","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/neuonc\/noaa092","volume":"22","author":"KD Westover","year":"2020","unstructured":"Westover KD, Mendel JT, Dan T, et al. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer[J]. Neuro Oncol. 2020;22:1831\u20139. https:\/\/doi.org\/10.1093\/neuonc\/noaa092.","journal-title":"Neuro Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12559-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12559-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12559-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:14:09Z","timestamp":1722028449000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12559-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12559"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12559-1","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"18 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of our hospital (17\/094-7845). Board Name: National GCP Center for Anticancer Drugs, The Independent Ethics Committee. Board Affiliation: National Cancer Center\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Informed consent to participate was obtained from all of the participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"899"}}